257 related articles for article (PubMed ID: 23863999)
1. CXCR4-mediated osteosarcoma growth and pulmonary metastasis is promoted by mesenchymal stem cells through VEGF.
Zhang P; Dong L; Yan K; Long H; Yang TT; Dong MQ; Zhou Y; Fan QY; Ma BA
Oncol Rep; 2013 Oct; 30(4):1753-61. PubMed ID: 23863999
[TBL] [Abstract][Full Text] [Related]
2. The HIF-1α/CXCR4 pathway supports hypoxia-induced metastasis of human osteosarcoma cells.
Guan G; Zhang Y; Lu Y; Liu L; Shi D; Wen Y; Yang L; Ma Q; Liu T; Zhu X; Qiu X; Zhou Y
Cancer Lett; 2015 Feb; 357(1):254-264. PubMed ID: 25444927
[TBL] [Abstract][Full Text] [Related]
3. CXCR4/TGF-β1 mediated self-differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and promoted colorectal carcinoma development.
Tan HX; Xiao ZG; Huang T; Fang ZX; Liu Y; Huang ZC
Cancer Biol Ther; 2020; 21(3):248-257. PubMed ID: 31818187
[No Abstract] [Full Text] [Related]
4. CXCR1/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis.
Du L; Han XG; Tu B; Wang MQ; Qiao H; Zhang SH; Fan QM; Tang TT
Cell Death Dis; 2018 Jun; 9(7):714. PubMed ID: 29915309
[TBL] [Abstract][Full Text] [Related]
5. CXCR4-targeted near-infrared imaging allows detection of orthotopic and metastatic human osteosarcoma in a mouse model.
Guan G; Lu Y; Zhu X; Liu L; Chen J; Ma Q; Zhang Y; Wen Y; Yang L; Liu T; Wang W; Ran H; Qiu X; Ke S; Zhou Y
Sci Rep; 2015 Oct; 5():15244. PubMed ID: 26472699
[TBL] [Abstract][Full Text] [Related]
6. Human mesenchymal stem cells (hMSCs) target osteosarcoma and promote its growth and pulmonary metastasis.
Xu WT; Bian ZY; Fan QM; Li G; Tang TT
Cancer Lett; 2009 Aug; 281(1):32-41. PubMed ID: 19342158
[TBL] [Abstract][Full Text] [Related]
7. Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression.
Perissinotto E; Cavalloni G; Leone F; Fonsato V; Mitola S; Grignani G; Surrenti N; Sangiolo D; Bussolino F; Piacibello W; Aglietta M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):490-7. PubMed ID: 15701832
[TBL] [Abstract][Full Text] [Related]
8. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
Gravina GL; Mancini A; Muzi P; Ventura L; Biordi L; Ricevuto E; Pompili S; Mattei C; Di Cesare E; Jannini EA; Festuccia C
Prostate; 2015 Sep; 75(12):1227-46. PubMed ID: 26073897
[TBL] [Abstract][Full Text] [Related]
9. Dynamic analysis of lung metastasis by mouse osteosarcoma LM8: VEGF is a candidate for anti-metastasis therapy.
Tanaka T; Yui Y; Naka N; Wakamatsu T; Yoshioka K; Araki N; Yoshikawa H; Itoh K
Clin Exp Metastasis; 2013 Apr; 30(4):369-79. PubMed ID: 23076771
[TBL] [Abstract][Full Text] [Related]
10. A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion.
Fontanella R; Pelagalli A; Nardelli A; D'Alterio C; Ieranò C; Cerchia L; Lucarelli E; Scala S; Zannetti A
Cancer Lett; 2016 Jan; 370(1):100-7. PubMed ID: 26517945
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro.
Guiducci S; Manetti M; Romano E; Mazzanti B; Ceccarelli C; Dal Pozzo S; Milia AF; Bellando-Randone S; Fiori G; Conforti ML; Saccardi R; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2011 Nov; 70(11):2011-21. PubMed ID: 21821866
[TBL] [Abstract][Full Text] [Related]
12. Trafficking mechanism of bone marrow-derived mesenchymal stem cells toward hepatocellular carcinoma HepG2 cells by modulating Endoglin, CXCR4 and TGF-β.
Mardomi A; Sabzichi M; Hussein Somi M; Shanehbandi D; Rahbarghazi R; Taj Sanjarani O; Samadi N
Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):81-86. PubMed ID: 27755957
[TBL] [Abstract][Full Text] [Related]
13. Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk.
Rhodes LV; Antoon JW; Muir SE; Elliott S; Beckman BS; Burow ME
Mol Cancer; 2010 Nov; 9():295. PubMed ID: 21087507
[TBL] [Abstract][Full Text] [Related]
14. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
Tu B; Du L; Fan QM; Tang Z; Tang TT
Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
[TBL] [Abstract][Full Text] [Related]
15. CXCR4-targeted therapy inhibits VEGF expression and chondrosarcoma angiogenesis and metastasis.
Sun X; Charbonneau C; Wei L; Yang W; Chen Q; Terek RM
Mol Cancer Ther; 2013 Jul; 12(7):1163-70. PubMed ID: 23686836
[TBL] [Abstract][Full Text] [Related]
16. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells promote tumor engraftment and metastatic colonization in rat osteosarcoma model.
Tsukamoto S; Honoki K; Fujii H; Tohma Y; Kido A; Mori T; Tsujiuchi T; Tanaka Y
Int J Oncol; 2012 Jan; 40(1):163-9. PubMed ID: 21971610
[TBL] [Abstract][Full Text] [Related]
18. SDF-1/CXCR4 promotes F5M2 osteosarcoma cell migration by activating the Wnt/β-catenin signaling pathway.
Lu Y; Hu B; Guan GF; Chen J; Wang CQ; Ma Q; Wen YH; Qiu XC; Zhang XP; Zhou Y
Med Oncol; 2015 Jul; 32(7):194. PubMed ID: 26026718
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stromal cells regulate the cell mobility and the immune response during osteogenesis through secretion of vascular endothelial growth factor A.
Zhou Y; Huang R; Fan W; Prasadam I; Crawford R; Xiao Y
J Tissue Eng Regen Med; 2018 Jan; 12(1):e566-e578. PubMed ID: 27696713
[TBL] [Abstract][Full Text] [Related]
20. AMD3100 combined with triptolide inhibit proliferation, invasion and metastasis and induce apoptosis of human U2OS osteosarcoma cells.
Jiang C; Fang X; Zhang H; Wang X; Li M; Jiang W; Tian F; Zhu L; Bian Z
Biomed Pharmacother; 2017 Feb; 86():677-685. PubMed ID: 28038429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
